Primarily used to promote ovulation in patients wishing to become pregnant:
- Danazol (Donocrine)
- Medroxyprogesterone acetate
- Clomiphene (Clomid)
- L-Norgestrel
- Tamoxifen (Nolvadex)
Considered a severe adverse effect associated with contraceptive agents:
- breakthrough bleeding
- changes in serum proteins
- gastrointestinal disorders
Factor(s) that increase risk of venous thrombosis in patients taking oral contraceptives:
- decrease in antithrombin III levels
- increased homocysteine levels
- injury
- A & B
- A, B & C
Considered serious adverse effects associated with contraceptive use:
- cancer
- depression
- myocardial infarction
- A & B
- A, B & C
Clinical uses of progestins:
- hormone replacement
- treatment of endometriosis
- treatment of hirsuitism
- treating premenstrual syndrome
- all the above
Consequence(s) of chronic combination contraceptive use:
- enhanced corpora lutea development
- enhanced follicular development
- stromal edema
- larger follicles
- none of the above
Change(s) in liver function associated with contraceptive hormone administration:
- altered drug excretion;changes in drug metabolism
- reduced cholelithiasis
- facilitated clearance of sulfobromophthalein
- increased bile flow
- all of the above
Adjunct hormonal therapy, particularly in estrogen-receptor-positive breast cancer:
- Medoxyprogesterone acetate
- Clomiphene (Clomid)
- Tamoxifen (Nolvadex)
- Danazol (Donocrine)
- all of the above
Selective nonsteroidal aromatase inhibitor; maybe useful in treating breast tumors
- danazol (Donocrine)
- anastrozole (Arimidex)
- tamoxifen (Nolvadex)
- A & B
- B & C
Contraceptive Contraindications or Cautions:
- edema
- asthma
- migraine
- A, B & C
- none of the above